Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Molecular predictors of 3D morphogenesis by breast cancer cell lines in 3D culture.

Han J, Chang H, Giricz O, Lee GY, Baehner FL, Gray JW, Bissell MJ, Kenny PA, Parvin B.

PLoS Comput Biol. 2010 Feb 26;6(2):e1000684. doi: 10.1371/journal.pcbi.1000684.

2.

Gene expression in the third dimension: the ECM-nucleus connection.

Spencer VA, Xu R, Bissell MJ.

J Mammary Gland Biol Neoplasia. 2010 Mar;15(1):65-71. doi: 10.1007/s10911-010-9163-3. Epub 2010 Jan 28. Review.

3.

Plasticity of cell migration: a multiscale tuning model.

Friedl P, Wolf K.

J Cell Biol. 2010 Jan 11;188(1):11-9. doi: 10.1083/jcb.200909003. Epub 2009 Dec 1. Review.

4.

A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion.

Brekhman V, Neufeld G.

BMC Cancer. 2009 Nov 30;9:415. doi: 10.1186/1471-2407-9-415.

5.

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

Iliopoulos D, Hirsch HA, Struhl K.

Cell. 2009 Nov 13;139(4):693-706. doi: 10.1016/j.cell.2009.10.014. Epub 2009 Oct 29.

6.

Cancer stem cells: mirage or reality?

Gupta PB, Chaffer CL, Weinberg RA.

Nat Med. 2009 Sep;15(9):1010-2. doi: 10.1038/nm0909-1010. Epub 2009 Sep 4. Review.

PMID:
19734877
7.

HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.

Weigelt B, Lo AT, Park CC, Gray JW, Bissell MJ.

Breast Cancer Res Treat. 2010 Jul;122(1):35-43. doi: 10.1007/s10549-009-0502-2. Epub 2009 Aug 22.

8.

Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.

Leivonen SK, Mäkelä R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellström K, Sahlberg N, Kristensen VN, Børresen-Dale AL, Saviranta P, Perälä M, Kallioniemi O.

Oncogene. 2009 Nov 5;28(44):3926-36. doi: 10.1038/onc.2009.241. Epub 2009 Aug 17.

PMID:
19684618
9.

Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES.

Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.

10.

Collagen-based cell migration models in vitro and in vivo.

Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, van Rheenen J, Deryugina E, Friedl P.

Semin Cell Dev Biol. 2009 Oct;20(8):931-41. doi: 10.1016/j.semcdb.2009.08.005. Epub 2009 Aug 12. Review.

11.

In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.

Guzmán-Ramírez N, Völler M, Wetterwald A, Germann M, Cross NA, Rentsch CA, Schalken J, Thalmann GN, Cecchini MG.

Prostate. 2009 Nov 1;69(15):1683-93. doi: 10.1002/pros.21018.

PMID:
19644960
12.

Anchorage-independent growth of prostate cancer stem cells.

Wang S.

Methods Mol Biol. 2009;568:151-60. doi: 10.1007/978-1-59745-280-9_9.

PMID:
19582425
13.

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells.

Kurrey NK, Jalgaonkar SP, Joglekar AV, Ghanate AD, Chaskar PD, Doiphode RY, Bapat SA.

Stem Cells. 2009 Sep;27(9):2059-68. doi: 10.1002/stem.154.

14.

The basics of epithelial-mesenchymal transition.

Kalluri R, Weinberg RA.

J Clin Invest. 2009 Jun;119(6):1420-8. doi: 10.1172/JCI39104. Review. Erratum in: J Clin Invest. 2010 May 3;120(5):1786.

15.

Mina Bissell: Context is everything. [An interview by Ben Short].

Bissell M.

J Cell Biol. 2009 May 4;185(3):374-5. doi: 10.1083/jcb.1853pi. No abstract available.

16.

WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.

Bisson I, Prowse DM.

Cell Res. 2009 Jun;19(6):683-97. doi: 10.1038/cr.2009.43.

PMID:
19365403
17.

Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.

Kawano Y, Diez S, Uysal-Onganer P, Darrington RS, Waxman J, Kypta RM.

Br J Cancer. 2009 Apr 7;100(7):1165-74. doi: 10.1038/sj.bjc.6604976. Epub 2009 Mar 10.

18.

The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers.

Wallerand H, Robert G, Pasticier G, Ravaud A, Ballanger P, Reiter RE, Ferrière JM.

Urol Oncol. 2010 Sep-Oct;28(5):473-9. doi: 10.1016/j.urolonc.2008.12.018. Epub 2009 Mar 9. Review.

PMID:
19272800
19.

Directional cell migration in vivo: Wnt at the crest.

Carmona-Fontaine C, Matthews H, Mayor R.

Cell Adh Migr. 2008 Oct-Dec;2(4):240-2. Epub 2008 Oct 5.

20.

Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.

Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB, Farrar WL.

Clin Exp Metastasis. 2009;26(5):433-46. doi: 10.1007/s10585-009-9242-2. Epub 2009 Feb 17.

Supplemental Content

Support Center